Journal
VACCINES
Volume 9, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/vaccines9121426
Keywords
systemic sclerosis; SARS-CoV-2; influenza; S; pneumoniae; hepatitis; HZV; N; meningitidis; H; influenzae; HPV; diphtheria-tetanus-pertussis
Categories
Ask authors/readers for more resources
This paper provides up-to-date evidence on vaccination strategies for patients with systemic sclerosis (SSc) to help prevent and manage infectious diseases, covering a range of vaccines including SARS-CoV-2, seasonal influenza, and others.
Systemic sclerosis (SSc) is a rare autoimmune inflammatory rheumatic disease. The prevalence of SSc ranges from 7 to 700 cases per million worldwide. Due to multiple organ involvement and constant inflammatory state, this group of patients presents an increased risk of infectious diseases. This paper aimed to gather the up-to-date evidence on vaccination strategies for patients with SSc and to be a useful tool for the prevention and management of infectious diseases. The authors conducted a scoping review in which each paragraph presents data on a specific vaccine's safety, immunogenicity, and efficacy. The work deals with the following topics: SARS-CoV-2, seasonal influenza, S. pneumoniae, HAV, HBV, HZV, N. meningitidis, H. influenzae, HPV, and diphtheria-tetanus-pertussis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available